Background. Despite small genomic differences, Chlamydia trachomatis biovars exhibit diverse disease manifestations and different growth rates in vivo and in cell culture models.
logenital strains are capable of infecting epithelial cells of both the conjunctiva and genital tract, they are distinct in terms of organ-specific disease. The disease spectrum of endemic trachoma strains is limited to chronic conjunctival infection, whereas oculogenital strains cause a self-limited form of acute conjunctivitis and a variety of acute and chronic genital tract infections. Genome studies have provided evidence that, despite large differences in disease potential, the different C. trachomatis serovars share 199.6% genetic identity [1] . Therefore, differences in virulence, pathogenic profile, and disease syndrome must be attributable to a relatively small number of genetic differences. Modest genomic differences must also dictate growth distinctions among closely related C. trachomatis serovars.
All chlamydiae share a unique obligate intracellular developmental cycle consisting of attachment and endocytosis by the infectious elementary body (EB) followed by primary differentiation to the metabolically active reticulate body (RB) within a host cell cytoplasmic vesicle. The RB replicates by binary fission until redifferentiation to EB occurs [2] ; this is followed by host cell lysis and EB release. The initial phase of attachment, endocytosis, and primary differentiation is equivalent to the conventional bacterial lag phase, in which bacteria adapt to the environment before division occurs. The phase of RB replication before EB redifferentiation is equivalent to the bacterial log phase. Typically, Chlamydia organisms are quantified by an infectivity assay in which EB measurements are taken over a time course (one-step growth curve); this assay provides a good estimate of the overall time to completion of the entire developmental cycle but does not provide information on the lag and log phases. The temporal relationship of these events has been characterized qualitatively by ultrastructural analysis and transcriptional experiments [3] but only to a limited extent by quantitative measurements of pathogen growth. Thus, it is not precisely clear why some chlamydial strains have developmental cycles of 36-48 h, whereas others require 72-96 h to complete the intracellular growth cycle.
Ocular strains are considered to be slow growing, genital strains are considered to grow at an intermediate rate, and LGV strains are considered to be fast growing. A reasonable explanation for these observations is that growth differences reflect differences in the efficiency with which particular developmental steps are completed. These same factors may also reflect tissue tropism and differences in disease manifestation. Comparison of growth rates, therefore, may ultimately identify genetic differences that contribute to chlamydial tissue tropism and disease indications. An earlier attempt to study the chlamydial log phase used radiolabeled uridine and quantified total DNA in cycloheximide-treated host cells infected with C. psittaci [4] ; the data suggested a 2-h generation time, which has been a generally accepted value. More-recent studies have used quantitative polymerase chain reaction (PCR) to measure levels of 16S rRNA [5, 6] or DNA [7] of C. trachomatis L2 and estimated the lag phase to be 6-8 h, with a generation time of 1.45-3.0 h. In each study, only 1 strain was evaluated, and, although basic growth-rate information was provided, details regarding times for cytokinesis and recovery of infectivity were lacking.
In the present study, we determined the length of the developmental cycle for representative examples of serovars A-F and L2 by use of one-step growth curves and then characterized the growth kinetics of representative C. trachomatis strains that exhibit rapid (L2), intermediate (D), and slow (A) growth characteristics in a human genital epithelial cell line (HeLa cells). We used the RB division rate in combination with a quantitative DNA assay and one-step growth curves to systematically evaluate chlamydial growth kinetics. We investigated the influence of host cell type by comparing the chlamydial growth characteristics observed in HeLa cells with those observed in diploid human conjunctival epithelial (HCjE) cells [8] . We also evaluated the effects that fast-and slow-growing chlamydial strains have on each other by comparing the growth patterns observed when cells were coinfected. The results demonstrated that classification of a strain as either fast or slow growing corresponded to pathotype (genital tract infection vs. endemic trachoma). Differences were the result of a longer lag phase and slower generation time for the ocular (serovar A) strain. Slow growth was partially ablated in HCjE cells or by coinfection with either serovar D or L2. These results suggest that differences in growth rates may be a reflection of the efficiency at which developmental stage-specific host-pathogen interactions occur. These interactions likely determine tissue tropism and disease type.
MATERIALS AND METHODS
Cell culture and growth of C. trachomatis. HeLa 229 cells were used for propagation of all C. trachomatis strains used in the present study. HeLa cells were grown in Dulbecco's modified Eagle's medium (DMEM; Biowhittaker) supplemented with 10% heat-inactivated fetal bovine serum (Hyclone), 10 mg/mL gentamicin, 2 mmol/L l-glutamine, 100 mmol/L HEPES buffer, 1 mmol/L sodium pyruvate, and 55 mmol/L b-mercaptoethanol (Gibco). Cells were maintained at 37ЊC in 7% CO 2 in cell culture flasks. C. trachomatis strains A/HAR-13, B/TW-5/OT, and C/TW-3/OT were propagated for 3 days, and strains D/UW-3/Cx, E/Bour (isolated from a patient with endemic trachoma [9] ), E/UW-5/Cx (isolated from a patient with cervicitis [10] ), F/UW6/Cx, and L2/434/Bu were propagated for 2 days, in HeLa cells pretreated with DEAE-dextran and 2 mg/ mL cycloheximide (Sigma). C. trachomatis were collected from infected-cell sonicates by differential centrifugation and were partially purified by centrifugation through 30% renografin (Bracco Diagnostics). Stock titers were determined by infectivity assay in thawed samples that had been stored at Ϫ80ЊC. HCjE cells (provided by I. Gipson, Department of Ophthalmology, Harvard Medical School) were propagated and maintained as described elsewhere [8] . HCjE cells were switched to DMEM/F12 medium with high calcium (1 mol/L CaCl 2 ) supplemented with 10% neonatal calf serum and 10 ng/mL epidermal growth factor, to promote stratification at confluence. RB growth curves. RB growth curves were made by arresting cell division in the presence of penicillin added at specified times after infection and enumerating aberrant RBs within an inclusion by light microscopy 2-3 days later [11] . HeLa cells were grown on 8-well chamber slides and infected with a low MOI of C. trachomatis serovar A, D, or L2 (cells infected, 0.2%-0.5%), to avoid inclusion fusion. Penicillin (50 mg/mL) was added to quadruplicate samples at appropriate times after infection. Infected cells were fixed in methanol; stained with Giemsa at 36, 42, and 66 h after infection for serovars L2, D, and A, respectively; and examined by light microscopy (magnification, ϫ1000). The number of large, aberrant RBs in each inclusion was counted and averaged. The RBs in at least 200 inclusions were enumerated at each time point.
Infection and preparation of cells for nucleic acid analysis and creation of one-step growth curves. HeLa or HCjE cells were plated onto 24-well plates at a density of cells/ 5 2 ϫ 10 well and incubated overnight. The cells were infected at an MOI of 0.3 in 0.2 mL of sucrose phosphate glutamate (SPG) and rocked at 37ЊC for 2 h. DMEM containing 2 mg/mL cycloheximide was added to HeLa cells, to compare strain-dependent growth differences. Stratification medium without cycloheximide (which is routinely used for HCjE cells) was added to HeLa and HCjE cells, to compare host cell-dependent growth differences for serovars A, D, and L2. The infected cells were incubated at 37ЊC in 7% CO 2 , collected in triplicate by scraping at appropriate times after infection, suspended in SPG in microtubes with glass beads, vortexed, and frozen at Ϫ80ЊC. Thawed samples were serially diluted and plated onto HeLa cell monolayers for infectivity determinations.
Assessment of chlamydial and host DNA. Total nucleic acid was prepared from snap-frozen pellets of infected cells by use of the DNeasy Tissue Kit (Qiagen), in accordance with the manufacturer's protocol. Chlamydial DNA was amplified by PCR with the oligonucleotides 5 -CATGCTGTGTGGGATTT-TGG-3 and 5 -CTGGCTATATATTCTACCGTTCCTGTTT-3 as specific primers and 5 -TATGCTTCTCCTTACTTTATTAC-GCA-3 as a probe for a 78-bp region of the C. trachomatis groEL2 gene. PCR was performed with Taq DNA polymerase (TaqMan PCR Master Mix Kit; Applied Biosystems). The host cell b-actin gene was amplified by PCR, to normalize the data on the basis of on host cell genome copy numbers (TaqMan b-actin control reagent; Applied Biosystems). Probes were labeled with the FAM reporter fluorochrome and the TAMRA quencher. Amplification conditions were 2 min at 50ЊC, then 10 min at 95ЊC, and the 40 cycles of 15 s at 95ЊC and 60 s at 60ЊC; the ABI Prism 7000 Sequence Detection System was used.
Coinfection and assessment of infectivity. HeLa cells were infected with either serovar A alone (MOI, 3), serovars A and D (MOI, 3 [for both]), or serovars A and L2 (MOI, 3 [for both]) in 1.5 mL of SPG and incubated at 37ЊC in 7% CO 2 in the presence of cycloheximide. Some cell monolayers were fixed in methanol and incubated with monoclonal antibody (MAb) specific for the MOMP of serovar A (A20) for 1 h, then incubated with goat anti-mouse antibody coupled with Alexa Fluor 555 (Invitrogen) for 1 h. Cells were then washed several times with PBS-azide and incubated with murine MAb specific for the MOMP of serovar D, E, or L2 directly coupled with fluorescein isothiocyanate (Argene). Other infected-cell samples were collected by scraping at 25, 27, and 29 h after infection, and infectivity was assessed for serovar A. spective of the time at which penicillin was added, but the average number of aberrant RBs within each inclusion was dependent on the time at which penicillin was added. Log 2 plots of the average number of aberrant RBs per inclusion provided generation-time estimates of 2.4 h for serovars D and L2 and 3.6 h for serovar A, by linear regression analysis ( figure  2A ). Serovar A completed the lag phase by 15 h after infection, whereas serovars D and L2 completed it by 10.5 and 8 h after infection, respectively.
RESULTS

Correlation
Correspondence between RB division and genomic replication, which was equal for serovars D and L2 but slower in serovar A. The relative increase in genome copy number closely paralleled the RB growth curve, indicating that cytokinesis was in balance with DNA replication ( figure 2A and  2B) . The genomic replication rate demonstrated that the generation time for serovars D and L2 were nearly equal at 2.2 and 2.4 h, whereas the generation time for serovar A was substantially longer (3.6 h). The exponential increase in genome copy number was linear until infectivity was confirmed (EB production), at which point it slowed substantially, indicating that conversion of RBs to EBs occurred relatively rapidly and, thus, limited further genomic replication. Comparison of genome copy numbers for E/UW5/Cx and E/Bour revealed a 2-h generation time for E/UW5/Cx but a significantly longer generation time for E/Bour (figure 2C). Thus, for these 2 serovar E strains, the genital strain exhibited growth characteristics similar to other genital strains, whereas the ocular strain exhibited growth characteristics similar to other ocular strains. A similar pattern was observed in the one-step growth curve ( figure 1) .
Expedition of the growth rate of an ocular strain in conjunctival epithelial cells. The growth rates of serovars A, D, and L2 in genital tract cells (HeLa) and conjunctival epithelial cells (HCjE) under identical growth conditions were compared. One-step growth curves in HeLa cells showed the initial emergence of infectious EBs at 21 h for serovar L2, at 24 h for serovar D, and at 30 h for serovar A (figure 3). One-step growth curves in HCjE cells for serovars A, D, and L2 showed that serovar D grew slowly and relatively poorly, whereas serovar A grew more rapidly, in comparison to growth in HeLa cells ( figure 3 ).
Expedited recovery of serovar A by coinfection with serovar D or L2. Coinfection resulted in single inclusions containing RBs and EBs for both infecting serovars (A and D or A and L2), indicating that these serovars can inhabit the same inclusion ( figure 4A-C) . Interestingly, coinfection with D or L2 resulted in the expedited recovery of infectious serovar A, compared with that of serovar A in the absence of faster strains ( figure 4D ). 
DISCUSSION
Comparison of the lengths of developmental cycles demonstrated that C. trachomatis isolates could be grouped into fast and slow strains that corresponded to genital and trachoma pathotypes, respectively. Interestingly, the 2 serovar E strains, E/Bour (isolated from a patient with endemic trachoma [9] ) and E/UW-5/Cx (isolated from a patient with cervicitis [10] ), corresponded to their original clinical presentations. These findings confirm reports indicating that endemic trachoma strains grow slower than do genital strains. However, an extensive assessment of clinical strains is needed to determine whether this observation can be generalized.
Oculogenital strains cause inclusion conjunctivitis and have the same tissue tropism as the endemic trachoma strains, despite differences in disease manifestation. Therefore, the difference in the progression of the developmental cycle is more likely to be reflective of disease type rather than tissue type. However, some reports have suggested that oculogenital strains obtained from neonates with inclusion conjunctivitis are slow growing [12] , providing evidence that ocular isolates may be genetically distinct variants of infecting strains selected during perinatal transmission. Comparison of the lengths of the developmental cycles of paired isolates obtained from a mother's genital tract and an infant's conjunctiva may provide definitive evidence with respect to these claims.
Systematic analysis of RB division, genomic replication, and infectivity provide an accurate temporal and quantitative assessment of chlamydial growth kinetics, including lag and log phases and terminal differentiation (RB to EB conversion). Measurement of these parameters for different C. trachomatis pathotypes has helped to explain why some chlamydial strains complete their developmental cycle rapidly and others require substantially longer periods of time. The initial lag phase consists of attachment, endocytosis, and primary differentiation to initiate replication; this phase is represented by very small increase in DNA content and minimal evidence of cytokinesis during the first several hours. The log phase consists of binary fission of metabolically active RBs and is represented by logarithmic increases in DNA content, which proceed and parallel cytokinesis. The log phase is followed by the conversion of RBs to EBs, which is represented by detection of infectious EBs coinciding with the decrease in DNA replication.
The ability to quantitatively determine chlamydial growth kinetics has practical applications in understanding disease pathogenesis and in evaluating the effects that antimicrobials or immune mediators have on C. trachomatis infection. In the present study, comparison of the growth kinetics of the different serovars demonstrated obvious differences in the developmental life cycles of the genital and trachoma strains. Systematic comparison of the specific parameters of growth (RB, genome, and EB) for serovars A, D, and L2 showed that the differences were attributable to the length of the lag phase and to the generation time (the log phase). Specifically, the lag phase was shortest for serovar L2, longest for serovar A, and in between for serovar D, with a difference of up to 6-8 h-indicating a difference in the efficiency of attachment, endocytosis, and/or primary differentiation. Several studies have shown that LGV strains are more efficient at attachment and uptake than are ocular strains. For example, ocular strains require pretreatment with DEAEdextran [13] or centrifugation [14] for efficient infection, whereas LGV strains maintain high infectivity without treatment. On attachment, C. trachomatis inject, via its type III secretion system, transmembrane actin-recruiting protein (Tarp) into the host cytoplasm [15] . Tarp is activated by tyrosine kinase-mediated phosphorylation, which results in actin recruitment to induce endocytosis of chlamydial EB. Serovar L2 has 6 repeats of the tyrosine-rich amino acid sequence, as opposed to 3 repeats for serovars A and D. This difference may, at least in part, account for the more-efficient entry process and the shorter lag phase observed for serovar L2. However, no clear association between Tarp polymorphism and organ specificity has been demonstrated by sequence analysis of 15 serovars [16] . Moreover, chlamydial uptake appears to occur relatively quickly in all strains examined to date [17] , suggesting that other factors associated with primary differentiation might contribute to the observed differences.
The generation times for serovars D and L2 were nearly identical, whereas the generation time for serovar A was substantially slower. The generation time for bacteria is determined by intrinsic and extrinsic (e.g., nutrients, pH, temperature, etc.) factors. In the present study, optimal growth conditions (medium enriched with cycloheximide) were applied to all strains, to highlight intrinsic differences. For other bacteria, generation time has been correlated with cell wall composition and altered activities of penicillin-binding proteins [18] , suggesting that the efficiency of cytokinesis regulates the DNA-replication rate. However, although the increase in the C. trachomatis genome copy numbers correlated with RB division here, previous studies have shown that genome copy numbers increase after penicillin treatment, suggesting that the rate of DNA replication is independent of cytokinesis for Chlamydia organisms [11] . Therefore, intrinsic differences that affect DNA replicationas well as transcription or translation-are candidates for further investigation.
The detailed mechanisms that account for the growth differences among pathotypes remain largely unknown. A recent report describes a slow-growing, nonfusogenic variant strain of C. trachomatis that is associated with milder clinical disease [19] . This finding highlights the possibility that differences in growth rates are a reflection of biological function and pathological differences. Comparison of the genomes of C. trachomatis serovars A and D reveal a relatively small net change of !2000 bp (out of 11 million bp), resulting in only a few candidate gene differences that might account for the differences in tissue tropism (ocular vs. genital) and disease manifestations among C. trachomatis pathotypes [16] . There are 8 predicted open reading frame interruptions in the serovar A genome, compared with the serovar D genome. Of these, tryptophan synthase and the chlamydial cytotoxin genes are functionally conserved in genital strains and have been implicated as immune-evasion mechanisms against the interferon-g-mediated antichlamydial effectors indoleamine deoxygenase and p47GTPases, respectively [20, 21] . Other interrupted genes, such as the arginine/ornithine antiporter (arcD) [22] , may impact l-arginine acquisition, which in turn could affect generation time; however, its role in chlamydial growth is unknown. Polymorphic membrane protein genes (pmpE, pmpF, and pmpH) are known to have a large number of single-nucleotide polymorphisms that correspond to pathobiotypes and also may play a role in tissue-specific host response and antigen recognition [16, 23] . However, given that the differences in growth rates we observed occurred after cycloheximide treatment, they are more likely to reflect differences in the intrinsic growth potential of the chlamydial strains investigated rather than effects of host immune responses. Other epigenomic changes may also be important in distinguishing pathotypes. These more-subtle differences include alterations in transcriptional patterns of commonly held genes, and further investigation is warranted.
Different growth conditions were found to influence the overall rate of growth as well. For example, the more-rapid initiation of RB-to-EB conversion for an ocular strain in conjunctival cells provides a hint that chlamydial growth may, at least in part, depend on host cell factors. Coinfection of cells with fast (serovars D or L2) and slow (serovar A) strains expedited the recovery of infectious EB for the slow-growing strain. This result demonstrates a gain of function for serovar A that may be attributable to alteration of the environment by a gene function that is active in the faster-growing serovar D or L2 isolate but not in the serovar A isolate. Our study shows that differences in the length of the developmental cycle between genital and ocular strains may be lessened in conditions that favor the ocular strains. This suggests that the rate of chlamydial growth is correlated with tropic cell type. Alteration of growth rates by targeting a specific step in the developmental cycle may be sought as a marker for pathotypic profiling. For example, interfering with the unique entry process of genital strains would be expected to prolong the lag phase for genital strains but not for trachoma strains. Examination of chlamydial clinical isolates by functional genomics may also reveal growth variants with differing potential to cause disease resulting from small genomic differences. These sorts of studies will be useful in refining our understanding of chlamydial pathogenesis at the molecular level.
